INLYTA (Axitinib) Tablets

What is Inlyta (Axitinib)
Inlyta is a targeted therapy and is a receptor protein-kinase inhibitor. Axitinib is the generic name.

INLYTA

Drug Manufacturer / Marketeer :

M/s Pfizer Inc.


Available as:

1MG & 5MG TABLETS.

Indications:
Inlyta® is indicated for treatment of advanced renal cell carcinoma after failure of 1 prior systemic therapy.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:

  • Inlyta 1 mg tablets are red film coated, oval tablets, available in
    bottles of 180
  • Inlyta 5 mg tablets are red film coated, triangular tablets available in bottles of 60

Storage and handling:
Store at 20° to 25° C, excursions permitted to 15° to 30° C

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s Pfizer Inc

Assistance Cell in India:
For ONCOLOGY DRUG: INLYTA (Axitinib) Tablets 1MG & 5MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.